Company news
Transcode Therapeutics, Inc. (NASDAQ:RNAZ) news
Transcode Therapeutics, Inc. news releases on 6ix. Latest, May 16, 2022: TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
Press releases — page 3
TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
May 15, 2022
TransCode Therapeutics Reports 2021 Results; Provides Business Update
March 30, 2022
TransCode Therapeutics Reports Business Progress and Third Quarter 2021 Financial Results
November 14, 2021
TransCode Therapeutics Announces Participation in the Q4 Virtual Investor Summit
November 8, 2021
TransCode Therapeutics Appoints Zdravka Medarova, Ph.D., as Chief Technology Officer
September 29, 2021
TransCode Therapeutics Announces Publication in Cancer Nanotechnology of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Metastatic Breast Cancer
September 22, 2021
TransCode Therapeutics Reports Business Progress and Second Quarter 2021 Financial Results
August 22, 2021
TransCode Therapeutics Awarded Funding from National Institutes of Health (NIH) to Support Clinical Evaluation of TTX-MC138
August 4, 2021
TransCode Therapeutics, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters' Over-allotment Option
July 12, 2021
TransCode Therapeutics, Inc. Announces Pricing of Initial Public Offering
July 7, 2021